Advisory Services Network’s ARK Genomic Revolution ETF ARKG Stock Holding History

Advisory Services Network’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.42M	Buy	105,088 +102,368	+3,764%	+$3.26M	0.05%	397
2026 Q1	$71.9K	Buy	+2,720	New	+$79.7K	﹤0.01%	2407
2025 Q4	–	Sell	-2,097	Closed	-$58.2K	–	1936
2025 Q3	$58.2K	Buy	+2,097	New	+$53K	﹤0.01%	2373
2024 Q1	–	Sell	-3,175	Closed	-$104K	–	1572
2023 Q4	$104K	Buy	+3,175	New	+$86.3K	﹤0.01%	1627
2023 Q2	–	Sell	-4,253	Closed	-$128K	–	1554
2023 Q1	$128K	Sell	4,253 -2,084	-33%	-$64.6K	﹤0.01%	1515
2022 Q4	$179K	Sell	6,337 -2,152	-25%	-$68.3K	0.01%	1320
2022 Q3	$279K	Sell	8,489 -144	-2%	-$5.29K	0.01%	1051
2022 Q2	$272K	Sell	8,633 -11,039	-56%	-$386K	0.01%	1116
2022 Q1	$904K	Sell	19,672 -2,256	-10%	-$108K	0.03%	657
2021 Q4	$1.34M	Sell	21,928 -3,430	-14%	-$237K	0.04%	517
2021 Q3	$1.9M	Buy	25,358 +2,656	+12%	+$223K	0.06%	399
2021 Q2	$2.1M	Sell	22,702 -16,267	-42%	-$1.38M	0.07%	378
2021 Q1	$3.46M	Buy	38,969 +23,677	+155%	+$2.35M	0.13%	205
2020 Q4	$1.43M	Buy	15,292 +2,880	+23%	+$229K	0.06%	392
2020 Q3	$791K	Buy	12,412 +5,138	+71%	+$301K	0.04%	480
2020 Q2	$379K	Buy	7,274 +3,436	+90%	+$147K	0.02%	701
2020 Q1	$120K	Buy	3,838 +1,452	+61%	+$48.5K	0.01%	987
2019 Q4	$80K	Buy	2,386 +10	+0.4%	+$318	﹤0.01%	1261
2019 Q3	$82K	Hold	2,376	–	–	0.01%	1145
2019 Q2	$82K	Sell	2,376 -235	-9%	-$7.53K	0.01%	1143
2019 Q1	$86K	Buy	2,611 +369	+16%	+$10.9K	0.01%	1047
2018 Q4	$54K	Buy	2,242 +765	+52%	+$21.6K	﹤0.01%	1110
2018 Q3	$49K	Buy	1,477 +107	+8%	+$3.39K	﹤0.01%	1234
2018 Q2	$41K	Buy	1,370 +330	+32%	+$9.19K	﹤0.01%	1277
2018 Q1	$27K	Buy	+1,040	New	+$28.2K	﹤0.01%	1528

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Advisory Services Network's ARKG Position: Q2 2026 in Review

Advisory Services Network increased its ARK Genomic Revolution ETF (ARKG) stake by 3,764% in Q2 2026, buying an estimated $3.26M and bringing the position to 105,088 shares worth $4.42M. The position accounts for 0.05% of the portfolio, ranked #397.

Advisory Services Network first reported a position in ARKG in Q1 2018 and has held it in 25 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Advisory Services Network held 105,088 shares of ARK Genomic Revolution ETF worth $4.42M as of Q2 2026.
Advisory Services Network bought 102,368 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $3.26M.
ARK Genomic Revolution ETF made up 0.05% of Advisory Services Network's portfolio in Q2 2026, its #397 holding.
Advisory Services Network first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 25 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.